{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T22:26:23Z","timestamp":1789424783115,"version":"build-2803163510"},"reference-count":126,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T00:00:00Z","timestamp":1739577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T00:00:00Z","timestamp":1739577600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-90083-3","type":"journal-article","created":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T12:42:51Z","timestamp":1739623371000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Extracellular vesicles efficiently deliver survival motor neuron protein to cells in culture"],"prefix":"10.1038","volume":"15","author":[{"given":"Charlotte A.","family":"Ren\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin J.","family":"Parks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,15]]},"reference":[{"key":"90083_CR1","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/0092-8674(95)90460-3","volume":"80","author":"S Lefebvre","year":"1995","unstructured":"Lefebvre, S. et al. Identification and characterization of a spinal muscular atrophy-determining gene. Cell 80, 155\u2013165. https:\/\/doi.org\/10.1016\/0092-8674(95)90460-3 (1995).","journal-title":"Cell"},{"key":"90083_CR2","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/ng0797-265","volume":"16","author":"S Lefebvre","year":"1997","unstructured":"Lefebvre, S. et al. Correlation between severity and SMN protein level in spinal muscular atrophy. Nat. Genet. 16, 265\u2013269. https:\/\/doi.org\/10.1038\/ng0797-265 (1997).","journal-title":"Nat. Genet."},{"key":"90083_CR3","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.ncl.2015.07.004","volume":"33","author":"SJ Kolb","year":"2015","unstructured":"Kolb, S. J. & Kissel, J. T. Spinal muscular atrophy. Neurol. Clin 33, 831\u2013846. https:\/\/doi.org\/10.1016\/j.ncl.2015.07.004 (2015).","journal-title":"Neurol. Clin"},{"key":"90083_CR4","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1002\/ana.25101","volume":"82","author":"SJ Kolb","year":"2017","unstructured":"Kolb, S. J. et al. Natural history of infantile-onset spinal muscular atrophy. Ann. Neurol. 82, 883\u2013891. https:\/\/doi.org\/10.1002\/ana.25101 (2017).","journal-title":"Ann. Neurol."},{"key":"90083_CR5","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1212\/WNL.0000000000000741","volume":"83","author":"RS Finkel","year":"2014","unstructured":"Finkel, R. S. et al. Observational study of spinal muscular atrophy type I and implications for clinical trials. Neurology 83, 810\u2013817. https:\/\/doi.org\/10.1212\/WNL.0000000000000741 (2014).","journal-title":"Neurology"},{"key":"90083_CR6","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.nmd.2016.06.459","volume":"26","author":"JK Burns","year":"2016","unstructured":"Burns, J. K., Kothary, R. & Parks, R. J. Opening the window: The case for carrier and perinatal screening for spinal muscular atrophy. Neuromuscul. Disord. 26, 551\u2013559. https:\/\/doi.org\/10.1016\/j.nmd.2016.06.459 (2016).","journal-title":"Neuromuscul. Disord."},{"key":"90083_CR7","doi-asserted-by":"publisher","first-page":"3895","DOI":"10.1093\/hmg\/ddq300","volume":"19","author":"AK Bevan","year":"2010","unstructured":"Bevan, A. K. et al. Early heart failure in the SMNDelta7 model of spinal muscular atrophy and correction by postnatal scAAV9-SMN delivery. Hum. Mol. Genet. 19, 3895\u20133905. https:\/\/doi.org\/10.1093\/hmg\/ddq300 (2010).","journal-title":"Hum. Mol. Genet."},{"key":"90083_CR8","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1016\/j.yjmcc.2012.01.005","volume":"52","author":"M Shababi","year":"2012","unstructured":"Shababi, M. et al. Partial restoration of cardio-vascular defects in a rescued severe model of spinal muscular atrophy. J. Mol. Cell Cardiol. 52, 1074\u20131082. https:\/\/doi.org\/10.1016\/j.yjmcc.2012.01.005 (2012).","journal-title":"J. Mol. Cell Cardiol."},{"key":"90083_CR9","doi-asserted-by":"publisher","first-page":"34635","DOI":"10.1038\/srep34635","volume":"6","author":"E Szunyogova","year":"2016","unstructured":"Szunyogova, E. et al. Survival Motor Neuron (SMN) protein is required for normal mouse liver development. Sci. Rep. 6, 34635. https:\/\/doi.org\/10.1038\/srep34635 (2016).","journal-title":"Sci. Rep."},{"key":"90083_CR10","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1002\/acn3.50855","volume":"6","author":"MO Deguise","year":"2019","unstructured":"Deguise, M. O. et al. Abnormal fatty acid metabolism is a core component of spinal muscular atrophy. Ann. Clin. Transl. Neurol. 6, 1519\u20131532. https:\/\/doi.org\/10.1002\/acn3.50855 (2019).","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"90083_CR11","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1093\/hmg\/ddw434","volume":"26","author":"MO Deguise","year":"2017","unstructured":"Deguise, M. O. et al. Immune dysregulation may contribute to disease pathogenesis in spinal muscular atrophy mice. Hum. Mol. Genet. 26, 801\u2013819. https:\/\/doi.org\/10.1093\/hmg\/ddw434 (2017).","journal-title":"Hum. Mol. Genet."},{"key":"90083_CR12","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1002\/ana.23582","volume":"72","author":"M Bowerman","year":"2012","unstructured":"Bowerman, M. et al. Glucose metabolism and pancreatic defects in spinal muscular atrophy. Ann. Neurol. 72, 256\u2013268. https:\/\/doi.org\/10.1002\/ana.23582 (2012).","journal-title":"Ann. Neurol."},{"key":"90083_CR13","doi-asserted-by":"publisher","first-page":"3432","DOI":"10.1093\/hmg\/ddu052","volume":"23","author":"M Bowerman","year":"2014","unstructured":"Bowerman, M. et al. Defects in pancreatic development and glucose metabolism in SMN-depleted mice independent of canonical spinal muscular atrophy neuromuscular pathology. Hum. Mol. Genet. 23, 3432\u20133444. https:\/\/doi.org\/10.1093\/hmg\/ddu052 (2014).","journal-title":"Hum. Mol. Genet."},{"key":"90083_CR14","doi-asserted-by":"publisher","first-page":"5665","DOI":"10.1093\/hmg\/ddv292","volume":"24","author":"SE Gombash","year":"2015","unstructured":"Gombash, S. E. et al. SMN deficiency disrupts gastrointestinal and enteric nervous system function in mice. Hum. Mol. Genet. 24, 5665. https:\/\/doi.org\/10.1093\/hmg\/ddv292 (2015).","journal-title":"Hum. Mol. Genet."},{"key":"90083_CR15","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/joa.12546","volume":"230","author":"AK Thomson","year":"2017","unstructured":"Thomson, A. K. et al. Survival of motor neurone protein is required for normal postnatal development of the spleen. J. Anat. 230, 337\u2013346. https:\/\/doi.org\/10.1111\/joa.12546 (2017).","journal-title":"J. Anat."},{"key":"90083_CR16","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1212\/WNL.0000000000002445","volume":"86","author":"CA Chiriboga","year":"2016","unstructured":"Chiriboga, C. A. et al. Results from a phase 1 study of nusinersen (ISIS-SMN(Rx)) in children with spinal muscular atrophy. Neurology 86, 890\u2013897. https:\/\/doi.org\/10.1212\/WNL.0000000000002445 (2016).","journal-title":"Neurology"},{"key":"90083_CR17","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1056\/NEJMoa2009965","volume":"384","author":"G Baranello","year":"2021","unstructured":"Baranello, G. et al. Risdiplam in Type 1 spinal muscular atrophy. N. Engl. J. Med. 384, 915\u2013923. https:\/\/doi.org\/10.1056\/NEJMoa2009965 (2021).","journal-title":"N. Engl. J. Med."},{"key":"90083_CR18","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1056\/NEJMoa170619810.1056\/NEJMoa1706198","volume":"377","author":"JR Mendell","year":"2017","unstructured":"Mendell, J. R. et al. Single-dose gene-replacement therapy for spinal muscular atrophy. N. Engl. J. Med. 377, 1713\u20131722. https:\/\/doi.org\/10.1056\/NEJMoa170619810.1056\/NEJMoa1706198 (2017).","journal-title":"N. Engl. J. Med."},{"key":"90083_CR19","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1056\/NEJMoa1710504","volume":"378","author":"E Mercuri","year":"2018","unstructured":"Mercuri, E. et al. Nusinersen versus sham control in later-onset spinal muscular atrophy. N. Engl. J. Med. 378, 625\u2013635. https:\/\/doi.org\/10.1056\/NEJMoa1710504 (2018).","journal-title":"N. Engl. J. Med."},{"key":"90083_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15061764","author":"CA Ren\u00e9","year":"2023","unstructured":"Ren\u00e9, C. A. & Parks, R. J. Expanding the availability of onasemnogene abeparvovec to older patients: The evolving treatment landscape for spinal muscular atrophy. Pharmaceutics https:\/\/doi.org\/10.3390\/pharmaceutics15061764 (2023).","journal-title":"Pharmaceutics"},{"key":"90083_CR21","unstructured":"Biogen. Spinraza prescribing information, <https:\/\/www.spinraza.com\/content\/dam\/commercial\/spinraza\/caregiver\/en_us\/pdf\/spinraza-prescribing-information.pdf> (2020)"},{"key":"90083_CR22","doi-asserted-by":"publisher","first-page":"6501","DOI":"10.1021\/acs.jmedchem.8b00741","volume":"61","author":"H Ratni","year":"2018","unstructured":"Ratni, H. et al. Discovery of risdiplam, a selective Survival of Motor Neuron-2 ( SMN2) gene splicing modifier for the treatment of Spinal Muscular Atrophy (SMA). J. Med. Chem. 61, 6501\u20136517. https:\/\/doi.org\/10.1021\/acs.jmedchem.8b00741 (2018).","journal-title":"J. Med. Chem."},{"key":"90083_CR23","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.jhep.2020.11.001","volume":"74","author":"D Chand","year":"2021","unstructured":"Chand, D. et al. Hepatotoxicity following administration of onasemnogene abeparvovec (AVXS-101) for the treatment of spinal muscular atrophy. J. Hepatol. 74, 560\u2013566. https:\/\/doi.org\/10.1016\/j.jhep.2020.11.001 (2021).","journal-title":"J. Hepatol."},{"key":"90083_CR24","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1212\/WNL.0000000000200676","volume":"98","author":"K Yazaki","year":"2022","unstructured":"Yazaki, K., Sakuma, S., Hikita, N., Fujimaru, R. & Hamazaki, T. Child neurology: pathologically confirmed thrombotic microangiopathy caused by onasemnogene abeparvovec treatment for SMA. Neurology 98, 808\u2013813. https:\/\/doi.org\/10.1212\/WNL.0000000000200676 (2022).","journal-title":"Neurology"},{"key":"90083_CR25","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1093\/hmg\/9.1.47","volume":"9","author":"S Pagliardini","year":"2000","unstructured":"Pagliardini, S. et al. Subcellular localization and axonal transport of the survival motor neuron (SMN) protein in the developing rat spinal cord. Hum. Mol. Genet. 9, 47\u201356. https:\/\/doi.org\/10.1093\/hmg\/9.1.47 (2000).","journal-title":"Hum. Mol. Genet."},{"key":"90083_CR26","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1093\/hmg\/6.8.1205","volume":"6","author":"DD Coovert","year":"1997","unstructured":"Coovert, D. D. et al. The survival motor neuron protein in spinal muscular atrophy. Hum. Mol. Genet. 6, 1205\u20131214. https:\/\/doi.org\/10.1093\/hmg\/6.8.1205 (1997).","journal-title":"Hum. Mol. Genet."},{"key":"90083_CR27","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.semcdb.2014.04.026","volume":"32","author":"DK Li","year":"2014","unstructured":"Li, D. K., Tisdale, S., Lotti, F. & Pellizzoni, L. SMN control of RNP assembly: from post-transcriptional gene regulation to motor neuron disease. Semin. Cell Dev. Biol. 32, 22\u201329. https:\/\/doi.org\/10.1016\/j.semcdb.2014.04.026 (2014).","journal-title":"Semin. Cell Dev. Biol."},{"key":"90083_CR28","doi-asserted-by":"publisher","first-page":"6307","DOI":"10.1073\/pnas.96.11.6307","volume":"96","author":"CL Lorson","year":"1999","unstructured":"Lorson, C. L., Hahnen, E., Androphy, E. J. & Wirth, B. A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy. Proc. Natl. Acad. Sci. U S A 96, 6307\u20136311. https:\/\/doi.org\/10.1073\/pnas.96.11.6307 (1999).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"90083_CR29","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/s0092-8674(00)80367-0","volume":"90","author":"Q Liu","year":"1997","unstructured":"Liu, Q., Fischer, U., Wang, F. & Dreyfuss, G. The spinal muscular atrophy disease gene product, SMN, and its associated protein SIP1 are in a complex with spliceosomal snRNP proteins. Cell 90, 1013\u20131021. https:\/\/doi.org\/10.1016\/s0092-8674(00)80367-0 (1997).","journal-title":"Cell"},{"key":"90083_CR30","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/s0092-8674(00)80368-2","volume":"90","author":"U Fischer","year":"1997","unstructured":"Fischer, U., Liu, Q. & Dreyfuss, G. The SMN-SIP1 complex has an essential role in spliceosomal snRNP biogenesis. Cell 90, 1023\u20131029. https:\/\/doi.org\/10.1016\/s0092-8674(00)80368-2 (1997).","journal-title":"Cell"},{"key":"90083_CR31","doi-asserted-by":"publisher","first-page":"27953","DOI":"10.1074\/jbc.M702317200","volume":"282","author":"DJ Battle","year":"2007","unstructured":"Battle, D. J., Kasim, M., Wang, J. & Dreyfuss, G. SMN-independent subunits of the SMN complex. Identification of a small nuclear ribonucleoprotein assembly intermediate. J. Biol. Chem. 282, 27953\u201327959. https:\/\/doi.org\/10.1074\/jbc.M702317200 (2007).","journal-title":"J. Biol. Chem."},{"key":"90083_CR32","doi-asserted-by":"publisher","first-page":"37009","DOI":"10.1074\/jbc.M607505200","volume":"281","author":"C Carissimi","year":"2006","unstructured":"Carissimi, C., Saieva, L., Gabanella, F. & Pellizzoni, L. Gemin8 is required for the architecture and function of the survival motor neuron complex. J. Biol. Chem. 281, 37009\u201337016. https:\/\/doi.org\/10.1074\/jbc.M607505200 (2006).","journal-title":"J. Biol. Chem."},{"key":"90083_CR33","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.2174\/15665240113139990044","volume":"13","author":"BB Goulet","year":"2013","unstructured":"Goulet, B. B., Kothary, R. & Parks, R. J. At the \u201cjunction\u201d of spinal muscular atrophy pathogenesis: the role of neuromuscular junction dysfunction in SMA disease progression. Curr. Mol. Med. 13, 1160\u20131174. https:\/\/doi.org\/10.2174\/15665240113139990044 (2013).","journal-title":"Curr. Mol. Med."},{"key":"90083_CR34","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/s0960-9822(01)00316-5","volume":"11","author":"L Pellizzoni","year":"2001","unstructured":"Pellizzoni, L., Baccon, J., Charroux, B. & Dreyfuss, G. The survival of motor neurons (SMN) protein interacts with the snoRNP proteins fibrillarin and GAR1. Curr. Biol. 11, 1079\u20131088. https:\/\/doi.org\/10.1016\/s0960-9822(01)00316-5 (2001).","journal-title":"Curr. Biol."},{"key":"90083_CR35","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1093\/hmg\/ddp009","volume":"18","author":"B Renvois\u00e9","year":"2009","unstructured":"Renvois\u00e9, B. et al. The loss of the snoRNP chaperone Nopp140 from Cajal bodies of patient fibroblasts correlates with the severity of spinal muscular atrophy. Hum. Mol. Genet. 18, 1181\u20131189. https:\/\/doi.org\/10.1093\/hmg\/ddp009 (2009).","journal-title":"Hum. Mol. Genet."},{"key":"90083_CR36","doi-asserted-by":"publisher","first-page":"3192","DOI":"10.1091\/mbc.e02-04-0216","volume":"13","author":"F Bachand","year":"2002","unstructured":"Bachand, F., Boisvert, F. M., C\u00f4t\u00e9, J., Richard, S. & Autexier, C. The product of the survival of motor neuron (SMN) gene is a human telomerase-associated protein. Mol. Biol. Cell. 13, 3192\u20133202. https:\/\/doi.org\/10.1091\/mbc.e02-04-0216 (2002).","journal-title":"Mol. Biol. Cell."},{"key":"90083_CR37","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1242\/bio.018804","volume":"5","author":"AR Poole","year":"2016","unstructured":"Poole, A. R. & Hebert, M. D. SMN and coilin negatively regulate dyskerin association with telomerase RNA. Biol. Open 5, 726\u2013735. https:\/\/doi.org\/10.1242\/bio.018804 (2016).","journal-title":"Biol. Open"},{"key":"90083_CR38","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a003558","author":"EH Blackburn","year":"2011","unstructured":"Blackburn, E. H. & Collins, K. Telomerase: an RNP enzyme synthesizes DNA. Cold Spring Harb. Perspect. Biol. https:\/\/doi.org\/10.1101\/cshperspect.a003558 (2011).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"90083_CR39","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1093\/hmg\/dds474","volume":"22","author":"G Sanchez","year":"2013","unstructured":"Sanchez, G. et al. A novel function for the survival motoneuron protein as a translational regulator. Hum. Mol. Genet. 22, 668\u2013684. https:\/\/doi.org\/10.1093\/hmg\/dds474 (2013).","journal-title":"Hum. Mol. Genet."},{"key":"90083_CR40","doi-asserted-by":"publisher","first-page":"3877","DOI":"10.1007\/s00018-018-2849-1","volume":"75","author":"H Chaytow","year":"2018","unstructured":"Chaytow, H., Huang, Y. T., Gillingwater, T. H. & Faller, K. M. E. The role of survival motor neuron protein (SMN) in protein homeostasis. Cell. & Mol. life sci.\u202f: CMLS 75, 3877\u20133894. https:\/\/doi.org\/10.1007\/s00018-018-2849-1 (2018).","journal-title":"Cell. & Mol. life sci. : CMLS"},{"key":"90083_CR41","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1038\/s41556-020-00577-7","volume":"22","author":"F Lauria","year":"2020","unstructured":"Lauria, F. et al. SMN-primed ribosomes modulate the translation of transcripts related to spinal muscular atrophy. Nat. cell boil. 22, 1239\u20131251. https:\/\/doi.org\/10.1038\/s41556-020-00577-7 (2020).","journal-title":"Nat. cell boil."},{"key":"90083_CR42","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1083\/jcb.200304128","volume":"163","author":"W Rossoll","year":"2003","unstructured":"Rossoll, W. et al. Smn, the spinal muscular atrophy-determining gene product, modulates axon growth and localization of beta-actin mRNA in growth cones of motoneurons. J. Cell Biol. 163, 801\u2013812. https:\/\/doi.org\/10.1083\/jcb.200304128 (2003).","journal-title":"J. Cell Biol."},{"key":"90083_CR43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0051826","volume":"7","author":"CH Ting","year":"2012","unstructured":"Ting, C. H. et al. The spinal muscular atrophy disease protein SMN is linked to the Golgi network. PLoS One 7, e51826. https:\/\/doi.org\/10.1371\/journal.pone.0051826 (2012).","journal-title":"PLoS One"},{"key":"90083_CR44","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.mcn.2009.05.009","volume":"42","author":"M Bowerman","year":"2009","unstructured":"Bowerman, M. et al. SMN, profilin IIa and plastin 3: a link between the deregulation of actin dynamics and SMA pathogenesis. Mol. Cell. Neurosci. 42, 66\u201374. https:\/\/doi.org\/10.1016\/j.mcn.2009.05.009 (2009).","journal-title":"Mol. Cell. Neurosci."},{"key":"90083_CR45","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1093\/hmg\/ddq021","volume":"19","author":"M Bowerman","year":"2010","unstructured":"Bowerman, M., Beauvais, A., Anderson, C. L. & Kothary, R. Rho-kinase inactivation prolongs survival of an intermediate SMA mouse model. Hum. Mol. Genet. 19, 1468\u20131478. https:\/\/doi.org\/10.1093\/hmg\/ddq021 (2010).","journal-title":"Hum. Mol. Genet."},{"key":"90083_CR46","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/nature16469","volume":"529","author":"DY Zhao","year":"2016","unstructured":"Zhao, D. Y. et al. SMN and symmetric arginine dimethylation of RNA polymerase II C-terminal domain control termination. Nature 529, 48\u201353. https:\/\/doi.org\/10.1038\/nature16469 (2016).","journal-title":"Nature"},{"key":"90083_CR47","doi-asserted-by":"publisher","first-page":"13859","DOI":"10.1038\/s41598-017-14313-z","volume":"7","author":"LA Nash","year":"2017","unstructured":"Nash, L. A. et al. Survival Motor Neuron Protein is released from cells in exosomes: A potential biomarker for spinal muscular atrophy. Sci. Rep. 7, 13859. https:\/\/doi.org\/10.1038\/s41598-017-14313-z (2017).","journal-title":"Sci. Rep."},{"key":"90083_CR48","doi-asserted-by":"publisher","first-page":"86999","DOI":"10.18632\/oncotarget.13569","volume":"7","author":"SN Hurwitz","year":"2016","unstructured":"Hurwitz, S. N. et al. Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers. Oncotarget 7, 86999\u201387015. https:\/\/doi.org\/10.18632\/oncotarget.13569 (2016).","journal-title":"Oncotarget"},{"key":"90083_CR49","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0067554","volume":"8","author":"G Skogberg","year":"2013","unstructured":"Skogberg, G. et al. Characterization of human thymic exosomes. PLoS One 8, e67554. https:\/\/doi.org\/10.1371\/journal.pone.0067554 (2013).","journal-title":"PLoS One"},{"key":"90083_CR50","doi-asserted-by":"publisher","DOI":"10.1002\/pmic.202200204","volume":"23","author":"X Xu","year":"2023","unstructured":"Xu, X. et al. Quantitative proteomic analysis of exosomes from umbilical cord mesenchymal stem cells and rat bone marrow stem cells. Proteomics 23, e2200204. https:\/\/doi.org\/10.1002\/pmic.202200204 (2023).","journal-title":"Proteomics"},{"key":"90083_CR51","doi-asserted-by":"publisher","first-page":"15297","DOI":"10.1038\/s41598-017-15717-7","volume":"7","author":"BJ Benedikter","year":"2017","unstructured":"Benedikter, B. J. et al. Ultrafiltration combined with size exclusion chromatography efficiently isolates extracellular vesicles from cell culture media for compositional and functional studies. Sci. Rep. 7, 15297. https:\/\/doi.org\/10.1038\/s41598-017-15717-7 (2017).","journal-title":"Sci. Rep."},{"key":"90083_CR52","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.jprot.2012.12.029","volume":"80","author":"B Liang","year":"2013","unstructured":"Liang, B. et al. Characterization and proteomic analysis of ovarian cancer-derived exosomes. J. Proteom. 80, 171\u2013182. https:\/\/doi.org\/10.1016\/j.jprot.2012.12.029 (2013).","journal-title":"J. Proteom."},{"key":"90083_CR53","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12404","volume":"13","author":"JA Welsh","year":"2024","unstructured":"Welsh, J. A. et al. Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches. J. Extracell. Vesicles 13, e12404. https:\/\/doi.org\/10.1002\/jev2.12404 (2024).","journal-title":"J. Extracell. Vesicles"},{"key":"90083_CR54","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1016\/j.jprot.2010.06.006","volume":"73","author":"S Mathivanan","year":"2010","unstructured":"Mathivanan, S., Ji, H. & Simpson, R. J. Exosomes: extracellular organelles important in intercellular communication. J. Proteom. 73, 1907\u20131920. https:\/\/doi.org\/10.1016\/j.jprot.2010.06.006 (2010).","journal-title":"J. Proteom."},{"key":"90083_CR55","doi-asserted-by":"publisher","first-page":"26316","DOI":"10.3402\/jev.v4.26316","volume":"4","author":"OP Wiklander","year":"2015","unstructured":"Wiklander, O. P. et al. Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting. J. Extracell. Vesicles 4, 26316. https:\/\/doi.org\/10.3402\/jev.v4.26316 (2015).","journal-title":"J. Extracell. Vesicles"},{"key":"90083_CR56","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aav8521","author":"OPB Wiklander","year":"2019","unstructured":"Wiklander, O. P. B., Brennan, M., L\u00f6tvall, J., Breakefield, X. O. & El Andaloussi, S. Advances in therapeutic applications of extracellular vesicles. Sci. Transl. Med. https:\/\/doi.org\/10.1126\/scitranslmed.aav8521 (2019).","journal-title":"Sci. Transl. Med."},{"key":"90083_CR57","doi-asserted-by":"publisher","first-page":"13853","DOI":"10.1021\/acsnano.9b04397","volume":"13","author":"G Morad","year":"2019","unstructured":"Morad, G. et al. Tumor-Derived Extracellular Vesicles Breach the Intact Blood-Brain Barrier. ACS Nano. 13, 13853\u201313865. https:\/\/doi.org\/10.1021\/acsnano.9b04397 (2019).","journal-title":"ACS Nano."},{"key":"90083_CR58","doi-asserted-by":"publisher","DOI":"10.1002\/jex2.59","author":"T Driedonks","year":"2022","unstructured":"Driedonks, T. et al. Pharmacokinetics and biodistribution of extracellular vesicles administered intravenously and intranasally to. J. Extracell. Biol. https:\/\/doi.org\/10.1002\/jex2.59 (2022).","journal-title":"J. Extracell. Biol."},{"key":"90083_CR59","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13040492","author":"CA Ren\u00e9","year":"2021","unstructured":"Ren\u00e9, C. A. & Parks, R. J. Delivery of therapeutic agents to the central nervous system and the promise of extracellular vesicles. Pharmaceutics https:\/\/doi.org\/10.3390\/pharmaceutics13040492 (2021).","journal-title":"Pharmaceutics"},{"key":"90083_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtm.2024.101259","volume":"32","author":"CA Ren\u00e9","year":"2024","unstructured":"Ren\u00e9, C. A. & Parks, R. J. Bioengineering extracellular vesicle cargo for optimal therapeutic efficiency. Mol. Ther. Methods Clin. Dev. 32, 101259. https:\/\/doi.org\/10.1016\/j.omtm.2024.101259 (2024).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"90083_CR61","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jconrel.2015.03.033","volume":"207","author":"MJ Haney","year":"2015","unstructured":"Haney, M. J. et al. Exosomes as drug delivery vehicles for Parkinson\u2019s disease therapy. J. Control. Release 207, 18\u201330. https:\/\/doi.org\/10.1016\/j.jconrel.2015.03.033 (2015).","journal-title":"J. Control. Release"},{"key":"90083_CR62","doi-asserted-by":"publisher","first-page":"45","DOI":"10.22037\/ijpr.2020.112062.13508","volume":"19","author":"M Izadpanah","year":"2020","unstructured":"Izadpanah, M. et al. Extracellular vesicles as a neprilysin delivery system memory Improvement in alzheimer\u2019s disease. Iran J. Pharm. Res. 19, 45\u201360. https:\/\/doi.org\/10.22037\/ijpr.2020.112062.13508 (2020).","journal-title":"Iran J. Pharm. Res."},{"key":"90083_CR63","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1139\/bcb-2012-0094","volume":"91","author":"BB Goulet","year":"2013","unstructured":"Goulet, B. B., McFall, E. R., Wong, C. M., Kothary, R. & Parks, R. J. Supraphysiological expression of survival motor neuron protein from an adenovirus vector does not adversely affect cell function. Biochem. Cell Biol. 91, 252\u2013264. https:\/\/doi.org\/10.1139\/bcb-2012-0094 (2013).","journal-title":"Biochem. Cell Biol."},{"key":"90083_CR64","doi-asserted-by":"publisher","DOI":"10.3390\/ijms231911915","author":"K Aoto","year":"2022","unstructured":"Aoto, K., Takabayashi, S., Mutoh, H. & Saitsu, H. Generation of Flag\/DYKDDDDK epitope tag knock-in mice using. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms231911915 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"90083_CR65","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1093\/nar\/gkz1145","volume":"48","author":"ES Babaylova","year":"2020","unstructured":"Babaylova, E. S. et al. mRNA regions where 80S ribosomes pause during translation elongation in vivo interact with protein uS19, a component of the decoding site. Nucleic Acids Res. 48, 912\u2013923. https:\/\/doi.org\/10.1093\/nar\/gkz1145 (2020).","journal-title":"Nucleic Acids Res."},{"key":"90083_CR66","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1089\/104303403321070874","volume":"14","author":"CJ DiDonato","year":"2003","unstructured":"DiDonato, C. J., Parks, R. J. & Kothary, R. Development of a gene therapy strategy for the restoration of survival motor neuron protein expression: implications for spinal muscular atrophy therapy. Hum. Gene. Ther. 14, 179\u2013188. https:\/\/doi.org\/10.1089\/104303403321070874 (2003).","journal-title":"Hum. Gene. Ther."},{"key":"90083_CR67","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1126\/science.6248960","volume":"209","author":"BB Knowles","year":"1980","unstructured":"Knowles, B. B., Howe, C. C. & Aden, D. P. Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen. Science 209, 497\u2013499. https:\/\/doi.org\/10.1126\/science.6248960 (1980).","journal-title":"Science"},{"key":"90083_CR68","doi-asserted-by":"publisher","first-page":"283","DOI":"10.2144\/000112243","volume":"41","author":"YA Bochkov","year":"2006","unstructured":"Bochkov, Y. A. & Palmenberg, A. C. Translational efficiency of EMCV IRES in bicistronic vectors is dependent upon IRES sequence and gene location. Biotechniques 41, 283\u2013284. https:\/\/doi.org\/10.2144\/000112243 (2006).","journal-title":"Biotechniques"},{"key":"90083_CR69","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1093\/hmg\/ddi168","volume":"14","author":"W Feng","year":"2005","unstructured":"Feng, W. et al. Gemins modulate the expression and activity of the SMN complex. Hum. Mol. Genet. 14, 1605\u20131611. https:\/\/doi.org\/10.1093\/hmg\/ddi168 (2005).","journal-title":"Hum. Mol. Genet."},{"key":"90083_CR70","doi-asserted-by":"publisher","first-page":"8126","DOI":"10.1074\/jbc.M512243200","volume":"281","author":"C Carissimi","year":"2006","unstructured":"Carissimi, C. et al. Gemin8 is a novel component of the survival motor neuron complex and functions in small nuclear ribonucleoprotein assembly. J. Biol. Chem. 281, 8126\u20138134. https:\/\/doi.org\/10.1074\/jbc.M512243200 (2006).","journal-title":"J. Biol. Chem."},{"key":"90083_CR71","doi-asserted-by":"publisher","DOI":"10.1242\/bio.032409","author":"ID Meier","year":"2018","unstructured":"Meier, I. D., Walker, M. P. & Matera, A. G. Gemin4 is an essential gene in mice, and its overexpression in human cells causes relocalization of the SMN complex to the nucleoplasm. Biol. Open https:\/\/doi.org\/10.1242\/bio.032409 (2018).","journal-title":"Biol. Open"},{"key":"90083_CR72","unstructured":"Ross, P. J. On the role of chromatin in the regulation of adenovirus vector transgene expression Doctorate of Philosophy thesis University of Ottawa (2009)."},{"key":"90083_CR73","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/0168-1702(88)90051-2","volume":"9","author":"GM Glenn","year":"1988","unstructured":"Glenn, G. M. & Ricciardi, R. P. Detailed kinetics of adenovirus type-5 steady-state transcripts during early infection. Virus Res. 9, 73\u201391. https:\/\/doi.org\/10.1016\/0168-1702(88)90051-2 (1988).","journal-title":"Virus Res."},{"key":"90083_CR74","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1046\/j.1365-2443.1998.00162.x","volume":"3","author":"Y Yamaguchi","year":"1998","unstructured":"Yamaguchi, Y., Wada, T. & Handa, H. Interplay between positive and negative elongation factors: drawing a new view of DRB. Genes Cells 3, 9\u201315. https:\/\/doi.org\/10.1046\/j.1365-2443.1998.00162.x (1998).","journal-title":"Genes Cells"},{"key":"90083_CR75","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1139\/bcb-2018-0117","volume":"96","author":"AN Giberson","year":"2018","unstructured":"Giberson, A. N. et al. Human adenoviral DNA association with nucleosomes containing histone variant H3.3 during the early phase of infection is not dependent on viral transcription or replication. Biochem. Cell Biol. 96, 797\u2013807. https:\/\/doi.org\/10.1139\/bcb-2018-0117 (2018).","journal-title":"Biochem. Cell Biol."},{"key":"90083_CR76","doi-asserted-by":"publisher","first-page":"3950","DOI":"10.1128\/JVI.01787-10","volume":"85","author":"PJ Ross","year":"2011","unstructured":"Ross, P. J. et al. Assembly of helper-dependent adenovirus DNA into chromatin promotes efficient gene expression. J. Virol. 85, 3950\u20133958. https:\/\/doi.org\/10.1128\/JVI.01787-10 (2011).","journal-title":"J. Virol."},{"key":"90083_CR77","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.pediatrneurol.2020.01.003","volume":"109","author":"CJJ Yeo","year":"2020","unstructured":"Yeo, C. J. J. & Darras, B. T. Overturning the paradigm of spinal muscular atrophy as just a motor neuron disease. Pediatr. Neurol. 109, 12\u201319. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2020.01.003 (2020).","journal-title":"Pediatr. Neurol."},{"key":"90083_CR78","doi-asserted-by":"publisher","first-page":"779","DOI":"10.2174\/1566524016666161128113338","volume":"16","author":"LA Nash","year":"2016","unstructured":"Nash, L. A., Burns, J. K., Chardon, J. W., Kothary, R. & Parks, R. J. Spinal muscular atrophy: More than a disease of motor neurons?. Curr. Mol. Med. 16, 779\u2013792. https:\/\/doi.org\/10.2174\/1566524016666161128113338 (2016).","journal-title":"Curr. Mol. Med."},{"key":"90083_CR79","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1056\/NEJMoa1702752","volume":"377","author":"RS Finkel","year":"2017","unstructured":"Finkel, R. S. et al. Nusinersen versus Sham control in infantile-onset spinal muscular atrophy. N. Engl. J. Med. 377, 1723\u20131732. https:\/\/doi.org\/10.1056\/NEJMoa1702752 (2017).","journal-title":"N. Engl. J. Med."},{"key":"90083_CR80","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3001777","author":"MA Passini","year":"2011","unstructured":"Passini, M. A. et al. Antisense oligonucleotides delivered to the mouse CNS ameliorate symptoms of severe spinal muscular atrophy. Sci. Transl. Med. https:\/\/doi.org\/10.1126\/scitranslmed.3001777 (2011).","journal-title":"Sci. Transl. Med."},{"key":"90083_CR81","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2024.100862","volume":"39","author":"R G\u00fcnther","year":"2024","unstructured":"G\u00fcnther, R. et al. Long-term efficacy and safety of nusinersen in adults with 5q spinal muscular atrophy: a prospective European multinational observational study. Lancet Reg. Health Eur. 39, 100862. https:\/\/doi.org\/10.1016\/j.lanepe.2024.100862 (2024).","journal-title":"Lancet Reg. Health Eur."},{"key":"90083_CR82","doi-asserted-by":"publisher","first-page":"175628641988761","DOI":"10.1177\/1756286419887616","volume":"13","author":"I Cordts","year":"2020","unstructured":"Cordts, I. et al. Intrathecal nusinersen administration in adult spinal muscular atrophy patients with complex spinal anatomy. Ther. Adv. Neurol. Disord. 13, 1756286419887616. https:\/\/doi.org\/10.1177\/1756286419887616 (2020).","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"90083_CR83","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/ene.15499","volume":"00","author":"E Mercuri","year":"2022","unstructured":"Mercuri, E. et al. Risdiplam in types 2 and 3 spinal muscular atrophy: A randomised, placebo-controlled, dose-finding trial followed by 24 months of treatment. Eur. J. Neurol. 00, 1\u201312. https:\/\/doi.org\/10.1111\/ene.15499 (2022).","journal-title":"Eur. J. Neurol."},{"issue":"4","key":"90083_CR84","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/s1474-4422(21)00001-6","volume":"20","author":"JW Day","year":"2021","unstructured":"Day, J. W. et al. Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy in patients with two copies of SMN2 (STR1VE): an open-label, single-arm, multicentre, phase 3 trial. Lancet Neurol. 20(4), 284\u2013293. https:\/\/doi.org\/10.1016\/s1474-4422(21)00001-6 (2021).","journal-title":"Lancet Neurol."},{"key":"90083_CR85","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1001\/jamaneurol.2021.1272","volume":"78","author":"JR Mendell","year":"2021","unstructured":"Mendell, J. R. et al. Five-Year Extension Results of the Phase 1 START Trial of Onasemnogene Abeparvovec in Spinal Muscular Atrophy. JAMA Neurol. 78, 834\u2013841. https:\/\/doi.org\/10.1001\/jamaneurol.2021.1272 (2021).","journal-title":"JAMA Neurol."},{"key":"90083_CR86","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/S1474-4422(21)00251-9","volume":"20","author":"E Mercuri","year":"2021","unstructured":"Mercuri, E. et al. Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy type 1 (STR1VE-EU): an open-label, single-arm, multicentre, phase 3 trial. Lancet Neurol. 20, 832\u2013841. https:\/\/doi.org\/10.1016\/S1474-4422(21)00251-9 (2021).","journal-title":"Lancet Neurol."},{"key":"90083_CR87","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1038\/s41591-022-01866-4","volume":"28","author":"KA Strauss","year":"2022","unstructured":"Strauss, K. A. et al. Onasemnogene abeparvovec for presymptomatic infants with two copies of SMN2 at risk for spinal muscular atrophy type 1: the Phase III SPR1NT trial. Nat. Med. 28, 1381\u20131389. https:\/\/doi.org\/10.1038\/s41591-022-01866-4 (2022).","journal-title":"Nat. Med."},{"key":"90083_CR88","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1038\/s41591-022-01867-3","volume":"28","author":"KA Strauss","year":"2022","unstructured":"Strauss, K. A. et al. Onasemnogene abeparvovec for presymptomatic infants with three copies of SMN2 at risk for spinal muscular atrophy: the Phase III SPR1NT trial. Nat. Med. 28, 1390\u20131397. https:\/\/doi.org\/10.1038\/s41591-022-01867-3 (2022).","journal-title":"Nat. Med."},{"key":"90083_CR89","unstructured":"Novartis. Novartis to initiate SMART Phase 3b global study of Zolgensma in children up to 21 kg, building on real-world experience <https:\/\/www.novartis.com\/news\/media-releases\/novartis-initiate-smart-phase-3b-global-study-zolgensma-children-21-kg-building-real-world-experience> (2021)"},{"key":"90083_CR90","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2023.113493","volume":"260","author":"J Gaillard","year":"2023","unstructured":"Gaillard, J., Gu, A. R. & Neil Knierbein, E. E. Necrotizing enterocolitis following onasemnogene abeparvovec for spinal muscular atrophy: A case series. J. Pediatr. 260, 113493. https:\/\/doi.org\/10.1016\/j.jpeds.2023.113493 (2023).","journal-title":"J. Pediatr."},{"key":"90083_CR91","unstructured":"Silverman, E. Novartis reports two children died from acute liver failure after treatment with Zolgensma gene therapy <https:\/\/www.statnews.com\/pharmalot\/2022\/08\/11\/novartis-zolgensma-liver-failure-gene-therapy-death\/> (2022)"},{"key":"90083_CR92","unstructured":"Novartis. Zolgensma acute liver failure update <https:\/\/www.novartis.com\/news\/zolgensma-acute-liver-failure-update> (2022)."},{"key":"90083_CR93","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.brainres.2003.09.063","volume":"995","author":"JW Francis","year":"2004","unstructured":"Francis, J. W. et al. A survival motor neuron:tetanus toxin fragment C fusion protein for the targeted delivery of SMN protein to neurons. Brain Res. 995, 84\u201396. https:\/\/doi.org\/10.1016\/j.brainres.2003.09.063 (2004).","journal-title":"Brain Res."},{"key":"90083_CR94","doi-asserted-by":"publisher","first-page":"8","DOI":"10.2478\/s13380-014-0201-2","volume":"5","author":"RS Anderton","year":"2014","unstructured":"Anderton, R. S., Meloni, B. P., Mastaglia, F. L. & Boulos, S. Investigation of a recombinant SMN protein delivery system to treat spinal muscular atrophy. Transl. Neurosci. 5, 8\u201316 (2014).","journal-title":"Transl. Neurosci."},{"key":"90083_CR95","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2023.106665","volume":"188","author":"TT Pham","year":"2023","unstructured":"Pham, T. T. et al. Endosomal escape of nucleic acids from extracellular vesicles mediates functional therapeutic delivery. Pharmacol. Res. 188, 106665. https:\/\/doi.org\/10.1016\/j.phrs.2023.106665 (2023).","journal-title":"Pharmacol. Res."},{"key":"90083_CR96","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s12195-016-0458-3","volume":"9","author":"CC Chen","year":"2016","unstructured":"Chen, C. C. et al. Elucidation of exosome migration across the blood-brain barrier model in vitro. Cell Mol. Bioeng. 9, 509\u2013529. https:\/\/doi.org\/10.1007\/s12195-016-0458-3 (2016).","journal-title":"Cell Mol. Bioeng."},{"key":"90083_CR97","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/s42255-023-00971-z","volume":"6","author":"PM Miotto","year":"2024","unstructured":"Miotto, P. M. et al. Liver-derived extracellular vesicles improve whole-body glycaemic control via inter-organ communication. Nat. Metab. 6, 254\u2013272. https:\/\/doi.org\/10.1038\/s42255-023-00971-z (2024).","journal-title":"Nat. Metab."},{"key":"90083_CR98","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1128\/MCB.01262-08","volume":"29","author":"BG Burnett","year":"2009","unstructured":"Burnett, B. G. et al. Regulation of SMN protein stability. Mol. Cell. Biol. 29, 1107\u20131115. https:\/\/doi.org\/10.1128\/MCB.01262-08 (2009).","journal-title":"Mol. Cell. Biol."},{"key":"90083_CR99","doi-asserted-by":"publisher","first-page":"43741","DOI":"10.1074\/jbc.M112.372318","volume":"287","author":"KJ Han","year":"2012","unstructured":"Han, K. J. et al. Ubiquitin-specific protease 9x deubiquitinates and stabilizes the spinal muscular atrophy protein-survival motor neuron. J. Biol. Chem. 287, 43741\u201343752. https:\/\/doi.org\/10.1074\/jbc.M112.372318 (2012).","journal-title":"J. Biol. Chem."},{"key":"90083_CR100","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.jconrel.2023.01.073","volume":"355","author":"B Lorenzini","year":"2023","unstructured":"Lorenzini, B. et al. Producing vesicle-free cell culture additive for human cells extracellular vesicles manufacturing. J. Control. Release 355, 501\u2013514. https:\/\/doi.org\/10.1016\/j.jconrel.2023.01.073 (2023).","journal-title":"J. Control. Release"},{"key":"90083_CR101","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/978-1-0716-3203-1_7","volume":"2668","author":"G Andriolo","year":"2023","unstructured":"Andriolo, G. et al. methodologies for scalable production of high-quality purified small extracellular vesicles from conditioned medium. Methods Mol. Biol. 2668, 69\u201398. https:\/\/doi.org\/10.1007\/978-1-0716-3203-1_7 (2023).","journal-title":"Methods Mol. Biol."},{"key":"90083_CR102","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2023.06.024","author":"AL Lightner","year":"2023","unstructured":"Lightner, A. L. et al. Bone marrow mesenchymal stem cell-derived extracellular vesicle infusion for the treatment of respiratory failure from COVID-19: A randomized. Placebo-Control. Dosing Clin. Trial. Chest https:\/\/doi.org\/10.1016\/j.chest.2023.06.024 (2023).","journal-title":"Placebo-Control. Dosing Clin. Trial. Chest"},{"key":"90083_CR103","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1007\/s12015-022-10398-w","volume":"18","author":"M Chu","year":"2022","unstructured":"Chu, M. et al. Nebulization Therapy with Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes for COVID-19 Pneumonia. Stem Cell Rev. Rep. 18, 2152\u20132163. https:\/\/doi.org\/10.1007\/s12015-022-10398-w (2022).","journal-title":"Stem Cell Rev. Rep."},{"key":"90083_CR104","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s13287-022-02900-5","volume":"13","author":"YG Zhu","year":"2022","unstructured":"Zhu, Y. G. et al. Nebulized exosomes derived from allogenic adipose tissue mesenchymal stromal cells in patients with severe COVID-19: a pilot study. Stem Cell Res. Ther. 13, 220. https:\/\/doi.org\/10.1186\/s13287-022-02900-5 (2022).","journal-title":"Stem Cell Res. Ther."},{"key":"90083_CR105","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aat5690","author":"M Guo","year":"2019","unstructured":"Guo, M. et al. Autologous tumor cell-derived microparticle-based targeted chemotherapy in lung cancer patients with malignant pleural effusion. Sci. Transl. Med. https:\/\/doi.org\/10.1126\/scitranslmed.aat5690 (2019).","journal-title":"Sci. Transl. Med."},{"key":"90083_CR106","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.nano.2015.10.012","volume":"12","author":"MS Kim","year":"2016","unstructured":"Kim, M. S. et al. Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells. Nanomedicine 12, 655\u2013664. https:\/\/doi.org\/10.1016\/j.nano.2015.10.012 (2016).","journal-title":"Nanomedicine"},{"key":"90083_CR107","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12332","volume":"12","author":"J Johnson","year":"2023","unstructured":"Johnson, J. et al. First-in-human clinical trial of allogeneic, platelet-derived extracellular vesicles as a potential therapeutic for delayed wound healing. J. Extracell. Vesicles 12, e12332. https:\/\/doi.org\/10.1002\/jev2.12332 (2023).","journal-title":"J. Extracell. Vesicles"},{"key":"90083_CR108","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1080\/10717544.2020.1869866","volume":"28","author":"JY Wu","year":"2021","unstructured":"Wu, J. Y., Li, Y. J., Hu, X. B., Huang, S. & Xiang, D. X. Preservation of small extracellular vesicles for functional analysis and therapeutic applications: a comparative evaluation of storage conditions. Drug Deliv. 28, 162\u2013170. https:\/\/doi.org\/10.1080\/10717544.2020.1869866 (2021).","journal-title":"Drug Deliv."},{"key":"90083_CR109","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12238","volume":"11","author":"A G\u00f6rgens","year":"2022","unstructured":"G\u00f6rgens, A. et al. Identification of storage conditions stabilizing extracellular vesicles preparations. J. Extracell. Vesicles 11, e12238. https:\/\/doi.org\/10.1002\/jev2.12238 (2022).","journal-title":"J. Extracell. Vesicles"},{"key":"90083_CR110","doi-asserted-by":"publisher","first-page":"1324730","DOI":"10.1080\/20013078.2017.1324730","volume":"6","author":"X Zhu","year":"2017","unstructured":"Zhu, X. et al. Comprehensive toxicity and immunogenicity studies reveal minimal effects in mice following sustained dosing of extracellular vesicles derived from HEK293T cells. J. Extracell. Vesicles 6, 1324730. https:\/\/doi.org\/10.1080\/20013078.2017.1324730 (2017).","journal-title":"J. Extracell. Vesicles"},{"key":"90083_CR111","doi-asserted-by":"publisher","first-page":"425","DOI":"10.3233\/JND-230122","volume":"11","author":"L Servais","year":"2024","unstructured":"Servais, L. et al. Real-world outcomes in patients with spinal muscular atrophy treated with onasemnogene abeparvovec monotherapy: findings from the RESTORE registry. J. Neuromuscul. Dis. 11, 425\u2013442. https:\/\/doi.org\/10.3233\/JND-230122 (2024).","journal-title":"J. Neuromuscul. Dis."},{"key":"90083_CR112","doi-asserted-by":"publisher","first-page":"2564","DOI":"10.1093\/hmg\/ddw119","volume":"25","author":"I Gallotta","year":"2016","unstructured":"Gallotta, I. et al. Neuron-specific knock-down of SMN1 causes neuron degeneration and death through an apoptotic mechanism. Hum. Mol. Genet. 25, 2564\u20132577. https:\/\/doi.org\/10.1093\/hmg\/ddw119 (2016).","journal-title":"Hum. Mol. Genet."},{"issue":"502","key":"90083_CR113","doi-asserted-by":"publisher","first-page":"e501","DOI":"10.1016\/j.ajog.2019.06.010","volume":"221","author":"S Sheller-Miller","year":"2019","unstructured":"Sheller-Miller, S., Choi, K., Choi, C. & Menon, R. Cyclic-recombinase-reporter mouse model to determine exosome communication and function during pregnancy. Am. J. Obstet. Gynecol. 221(502), e501-502.e512. https:\/\/doi.org\/10.1016\/j.ajog.2019.06.010 (2019).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"90083_CR114","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/S1474-4422(20)30037-5","volume":"19","author":"T Hagenacker","year":"2020","unstructured":"Hagenacker, T. et al. Nusinersen in adults with 5q spinal muscular atrophy: a non-interventional, multicentre, observational cohort study. Lancet Neurol. 19, 317\u2013325. https:\/\/doi.org\/10.1016\/S1474-4422(20)30037-5 (2020).","journal-title":"Lancet Neurol."},{"key":"90083_CR115","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1056\/NEJMoa2102047","volume":"385","author":"BT Darras","year":"2021","unstructured":"Darras, B. T. et al. Risdiplam-treated infants with type 1 spinal muscular atrophy versus historical controls. N. Engl. J. Med. 385, 427\u2013435. https:\/\/doi.org\/10.1056\/NEJMoa2102047 (2021).","journal-title":"N. Engl. J. Med."},{"key":"90083_CR116","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.447","volume":"6","author":"A Poirier","year":"2018","unstructured":"Poirier, A. et al. Risdiplam distributes and increases SMN protein in both the central nervous system and peripheral organs. Pharmacol. Res. Perspect 6, e00447. https:\/\/doi.org\/10.1002\/prp2.447 (2018).","journal-title":"Pharmacol. Res. Perspect"},{"key":"90083_CR117","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1038\/s41591-021-01483-7","volume":"27","author":"G Thomsen","year":"2021","unstructured":"Thomsen, G. et al. Biodistribution of onasemnogene abeparvovec DNA, mRNA and SMN protein in human tissue. Nat. Med. 27, 1701\u20131711. https:\/\/doi.org\/10.1038\/s41591-021-01483-7 (2021).","journal-title":"Nat. Med."},{"key":"90083_CR118","doi-asserted-by":"publisher","first-page":"3017","DOI":"10.1016\/S0140-6736(16)31408-8","volume":"388","author":"RS Finkel","year":"2016","unstructured":"Finkel, R. S. et al. Treatment of infantile-onset spinal muscular atrophy with nusinersen: a phase 2, open-label, dose-escalation study. Lancet 388, 3017\u20133026. https:\/\/doi.org\/10.1016\/S0140-6736(16)31408-8 (2016).","journal-title":"Lancet"},{"key":"90083_CR119","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0113651","volume":"9","author":"D Povero","year":"2014","unstructured":"Povero, D. et al. Circulating extracellular vesicles with specific proteome and liver microRNAs are potential biomarkers for liver injury in experimental fatty liver disease. PLoS One 9, e113651. https:\/\/doi.org\/10.1371\/journal.pone.0113651 (2014).","journal-title":"PLoS One"},{"key":"90083_CR120","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1002\/cpt.2102","volume":"109","author":"B Achour","year":"2021","unstructured":"Achour, B. et al. liquid biopsy enables quantification of the abundance and interindividual variability of hepatic enzymes and transporters. Clin. Pharmacol. Ther. 109, 222\u2013232. https:\/\/doi.org\/10.1002\/cpt.2102 (2021).","journal-title":"Clin. Pharmacol. Ther."},{"key":"90083_CR121","doi-asserted-by":"publisher","first-page":"653","DOI":"10.3233\/JND-230012","volume":"10","author":"S Trifunov","year":"2023","unstructured":"Trifunov, S. et al. Full-length SMN transcript in extracellular vesicles as biomarker in individuals with spinal muscular atrophy type 2 treated with nusinersen. J. Neuromuscul. Dis. 10, 653\u2013665. https:\/\/doi.org\/10.3233\/JND-230012 (2023).","journal-title":"J. Neuromuscul. Dis."},{"key":"90083_CR122","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1093\/jnci\/51.5.1417","volume":"51","author":"DJ Giard","year":"1973","unstructured":"Giard, D. J. et al. In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J. Natl. Cancer Inst. 51, 1417\u20131423. https:\/\/doi.org\/10.1093\/jnci\/51.5.1417 (1973).","journal-title":"J. Natl. Cancer Inst."},{"key":"90083_CR123","doi-asserted-by":"publisher","DOI":"10.1101\/pdb.prot5011","author":"PJ Ross","year":"2009","unstructured":"Ross, P. J. & Parks, R. J. Construction and characterization of adenovirus vectors. Cold Spring Harb. Protoc. https:\/\/doi.org\/10.1101\/pdb.prot5011 (2009).","journal-title":"Cold Spring Harb. Protoc."},{"key":"90083_CR124","doi-asserted-by":"publisher","DOI":"10.1002\/0471143030.cb0322s30","author":"C Th\u00e9ry","year":"2006","unstructured":"Th\u00e9ry, C., Amigorena, S., Raposo, G. & Clayton, A. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr. Protoc. Cell Biol. https:\/\/doi.org\/10.1002\/0471143030.cb0322s30 (2006).","journal-title":"Curr. Protoc. Cell Biol."},{"key":"90083_CR125","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin, J. et al. Fiji: an open-source platform for biological-image analysis. Nat. Methods 9, 676\u2013682. https:\/\/doi.org\/10.1038\/nmeth.2019 (2012).","journal-title":"Nat. Methods"},{"key":"90083_CR126","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1186\/s12859-021-04344-9","volume":"22","author":"DR Stirling","year":"2021","unstructured":"Stirling, D. R. et al. Cell Profiler 4: improvements in speed, utility and usability. BMC Bioinform. 22, 433. https:\/\/doi.org\/10.1186\/s12859-021-04344-9 (2021).","journal-title":"BMC Bioinform."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-90083-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-90083-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-90083-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T12:42:56Z","timestamp":1739623376000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-90083-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,15]]},"references-count":126,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["90083"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-90083-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,15]]},"assertion":[{"value":"11 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5674"}}